Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Adam Fischer, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Michael Fischer and Philip Wang.
Michael Fischer
Connection Strength
0.613
Philip Wang
  1. Restrictions on antidepressant medications for children: a review of Medicaid policy. Psychiatr Serv. 2007 Jan; 58(1):135-8.
    View in: PubMed
    Score: 0.346
  2. Medicaid's prior authorization program and access to atypical antipsychotic medications. Health Aff (Millwood). 2007 May-Jun; 26(3):750-60.
    View in: PubMed
    Score: 0.088
  3. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005 Dec 01; 353(22):2335-41.
    View in: PubMed
    Score: 0.080
  4. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension. 2005 Aug; 46(2):273-9.
    View in: PubMed
    Score: 0.078
  5. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis. 2005 Dec; 46(6):1080-7.
    View in: PubMed
    Score: 0.020
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.